BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Amioka A, Masumoto N, Gouda N, Kajitani K, Shigematsu H, Emi A, Kadoya T, Okada M. Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy. Jpn J Clin Oncol 2016;46:303-9. [PMID: 26848078 DOI: 10.1093/jjco/hyv215] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Kong X, Zhang Q, Wu X, Zou T, Duan J, Song S, Nie J, Tao C, Tang M, Wang M, Zou J, Xie Y, Li Z, Li Z. Advances in Imaging in Evaluating the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer. Front Oncol 2022;12:816297. [DOI: 10.3389/fonc.2022.816297] [Reference Citation Analysis]
2 Lee SC, Tchelepi H, Khadem N, Desai B, Yamashita M, Hovanessian-Larsen L. Imaging of Benign and Malignant Breast Lesions Using Contrast-Enhanced Ultrasound: A Pictorial Essay. Ultrasound Q 2022;38:2-12. [PMID: 35239626 DOI: 10.1097/RUQ.0000000000000574] [Reference Citation Analysis]
3 Yan Y, Tang L, Huang H, Yu Q, Xu H, Chen Y, Chen M, Zhang Q. Four-quadrant fast compressive tracking of breast ultrasound videos for computer-aided response evaluation of neoadjuvant chemotherapy in mice. Comput Methods Programs Biomed 2022;217:106698. [PMID: 35217304 DOI: 10.1016/j.cmpb.2022.106698] [Reference Citation Analysis]
4 Wang J, Chu Y, Wang B, Jiang T. A Narrative Review of Ultrasound Technologies for the Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer. Cancer Manag Res 2021;13:7885-95. [PMID: 34703310 DOI: 10.2147/CMAR.S331665] [Reference Citation Analysis]
5 Rix A, Piepenbrock M, Flege B, von Stillfried S, Koczera P, Opacic T, Simons N, Boor P, Thoröe-Boveleth S, Deckers R, May JN, Lammers T, Schmitz G, Stickeler E, Kiessling F. Effects of contrast-enhanced ultrasound treatment on neoadjuvant chemotherapy in breast cancer. Theranostics 2021;11:9557-70. [PMID: 34646386 DOI: 10.7150/thno.64767] [Reference Citation Analysis]
6 Peng J, Pu H, Jia Y, Chen C, Ke XK, Zhou Q. Early prediction of response to neoadjuvant chemotherapy using contrast-enhanced ultrasound in breast cancer. Medicine (Baltimore) 2021;100:e25908. [PMID: 34106653 DOI: 10.1097/MD.0000000000025908] [Reference Citation Analysis]
7 Winder AA, Dijkstra B. Is pathological complete response predictable after neoadjuvant chemotherapy in breast cancer? A single institution's retrospective experience. ANZ J Surg 2021;91:1779-83. [PMID: 34056804 DOI: 10.1111/ans.16966] [Reference Citation Analysis]
8 Sharma A, Grover SB, Mani C, Ahluwalia C. Contrast enhanced ultrasound quantitative parameters for assessing neoadjuvant chemotherapy response in patients with locally advanced breast cancer. Br J Radiol 2021;94:20201160. [PMID: 33860674 DOI: 10.1259/bjr.20201160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Huang Y, Le J, Miao A, Zhi W, Wang F, Chen Y, Zhou S, Chang C. Prediction of treatment responses to neoadjuvant chemotherapy in breast cancer using contrast-enhanced ultrasound. Gland Surg 2021;10:1280-90. [PMID: 33968680 DOI: 10.21037/gs-20-836] [Reference Citation Analysis]
10 Zubair M, Wang S, Ali N. Advanced Approaches to Breast Cancer Classification and Diagnosis. Front Pharmacol 2020;11:632079. [PMID: 33716731 DOI: 10.3389/fphar.2020.632079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Boca Bene I, Dudea SM, Ciurea AI. Contrast-Enhanced Ultrasonography in the Diagnosis and Treatment Modulation of Breast Cancer. J Pers Med 2021;11:81. [PMID: 33573122 DOI: 10.3390/jpm11020081] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yixin HM, Fei LM, Jianhua ZM. Current Status and Advances in Imaging Evaluation of Neoadjuvant Chemotherapy of Breast Cancer. Advanced Ultrasound in Diagnosis and Therapy 2021;5:18. [DOI: 10.37015/audt.2021.190036] [Reference Citation Analysis]
13 Leng X, Huang G, Zhang L, Ding J, Ma F. Changes in Tumor Stem Cell Markers and Epithelial-Mesenchymal Transition Markers in Nonluminal Breast Cancer after Neoadjuvant Chemotherapy and Their Correlation with Contrast-Enhanced Ultrasound. Biomed Res Int 2020;2020:3869538. [PMID: 33282946 DOI: 10.1155/2020/3869538] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Zhang Y, Zhang B, Fan X, Mao D. Clinical value and application of contrast-enhanced ultrasound in the differential diagnosis of malignant and benign breast lesions. Exp Ther Med 2020;20:2063-9. [PMID: 32782518 DOI: 10.3892/etm.2020.8895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Li J, Yuan M, Yang L, Guo L. Correlation of contrast-enhanced ultrasound features with prognostic factors in invasive ductal carcinomas of the breast. Jpn J Radiol 2020;38:960-7. [PMID: 32500174 DOI: 10.1007/s11604-020-00994-6] [Reference Citation Analysis]
16 Gu LS, Zhang R, Wang Y, Liu XM, Ma F, Wang JY, Sun XY, Liu MJ, Wang B, Zou SM. Characteristics of contrast-enhanced ultrasonography and strain elastography of locally advanced breast cancer. J Thorac Dis 2019;11:5274-89. [PMID: 32030245 DOI: 10.21037/jtd.2019.11.52] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Wang B, Jiang T, Huang M, Wang J, Chu Y, Zhong L, Zheng S. Evaluation of the response of breast cancer patients to neoadjuvant chemotherapy by combined contrast-enhanced ultrasonography and ultrasound elastography. Exp Ther Med 2019;17:3655-63. [PMID: 30988749 DOI: 10.3892/etm.2019.7353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
18 Jia K, Li L, Wu XJ, Hao MJ, Xue HY. Contrast-enhanced ultrasound for evaluating the pathologic response of breast cancer to neoadjuvant chemotherapy: A meta-analysis. Medicine (Baltimore) 2019;98:e14258. [PMID: 30681622 DOI: 10.1097/MD.0000000000014258] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
19 Li J, Guo L, Yin L, Fang H, Ye W, Zhao B, Liu Y, Xu T. Can different regions of interest influence the diagnosis of benign and malignant breast lesions using quantitative parameters of contrast-enhanced sonography? Eur J Radiol 2018;108:1-6. [PMID: 30396640 DOI: 10.1016/j.ejrad.2018.09.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
20 Hayashi N, Tsunoda H, Namura M, Ochi T, Suzuki K, Yamauchi H, Nakamura S. Magnetic Resonance Imaging Combined With Second-look Ultrasonography in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Primary Breast Cancer Patients. Clin Breast Cancer 2019;19:71-7. [PMID: 30206035 DOI: 10.1016/j.clbc.2018.08.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
21 Wan CF, Liu XS, Wang L, Zhang J, Lu JS, Li FH. Quantitative contrast-enhanced ultrasound evaluation of pathological complete response in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy. Eur J Radiol 2018;103:118-23. [PMID: 29803376 DOI: 10.1016/j.ejrad.2018.04.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
22 Chen L, Yang Q, Bao J, Liu D, Huang X, Wang J. Direct comparison of PET/CT and MRI to predict the pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis. Sci Rep 2017;7:8479. [PMID: 28814795 DOI: 10.1038/s41598-017-08852-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
23 Rauch GM, Adrada BE, Kuerer HM, van la Parra RFD, Leung JWT, Yang WT. Multimodality Imaging for Evaluating Response to Neoadjuvant Chemotherapy in Breast Cancer. American Journal of Roentgenology 2017;208:290-9. [DOI: 10.2214/ajr.16.17223] [Cited by in Crossref: 41] [Cited by in F6Publishing: 16] [Article Influence: 8.2] [Reference Citation Analysis]
24 Song JL, Chen C, Yuan JP, Sun SR. Progress in the clinical detection of heterogeneity in breast cancer. Cancer Med 2016;5:3475-88. [PMID: 27774765 DOI: 10.1002/cam4.943] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 5.2] [Reference Citation Analysis]